Illumina (ILMN) had one of those after-hours reactions that is probably going to look stupid. They had a great quarter, with sales growing 24% , which was a bit higher than expected. EPS growth was strong and ahead of consensus too. Sales guidance had been expected at +11% but was +13% (off a slightly higher base). The stock sold off on weak EPS guidance 0f 1.55-1.62 compared to the consensus of 1.72, but the company called out heavy R&D spending and two investments in programs to improve efficiency. This is a pretty complex company. I could be wrong, but this actually sounded good to me.
I am thinking that this island gets revisited (55 area):
Comments
You can follow this conversation by subscribing to the comment feed for this post.